MENU
HTEC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

HTEC stock forecast, quote, news & analysis

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index... Show more

Category: #Health
HTEC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for HTEC with price predictions
Jul 31, 2026

Momentum Indicator for HTEC turns positive, indicating new upward trend

HTEC saw its Momentum Indicator move above the 0 level on July 28, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HTEC advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 223 cases where HTEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HTEC moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for HTEC turned negative on July 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HTEC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HTEC broke above its upper Bollinger Band on June 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Bristol-Myers Squibb Co (NYSE:BMY), Intuitive Surgical (NASDAQ:ISRG), Regeneron Pharmaceuticals (NASDAQ:REGN), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA).

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Market Cap

The average market capitalization across the Robo Global® Hlthcare Tech & Innovt ETF ETF is 30.61B. The market cap for tickers in the group ranges from 1.21B to 213.42B. TMO holds the highest valuation in this group at 213.42B. The lowest valued company is STAA at 1.21B.

High and low price notable news

The average weekly price growth across all stocks in the Robo Global® Hlthcare Tech & Innovt ETF ETF was 3%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 5%. CDNA experienced the highest price growth at 18%, while ALNY experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Robo Global® Hlthcare Tech & Innovt ETF ETF was 19%. For the same stocks of the ETF, the average monthly volume growth was 3% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 56
Price Growth Rating: 43
SMR Rating: 74
Profit Risk Rating: 87
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
HTEC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
3555 Northwest 58th StreetSuite 410Oklahoma City
Phone
+1 405 7788377
Web
www.exchangetradedconcepts.com
Momentum Indicator for HTEC turns positive, indicating new upward trend